AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CEFAZOLINE

8 registrations across 3 African markets— 5 active

Markets with CEFAZOLINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
CEFAZOL IM
Pdre p.prep.injectable / 1 gr
🇹🇳TunisiaUNIMEDexpiredJul 2003
CEFAZOL IM IV
Pdre p.prep.injectable / 1 GR
🇹🇳TunisiaUNIMEDexpiredDec 2002
CEFAZOL IM IV
Pdre p.prep.injectable / 1 GR
🇹🇳TunisiaUNIMEDexpiredDec 2002
FAZLIN
poudre pour préparation injectable / 1g
🇸🇳SenegalNCPC HEBEL HUAMIN PHARMACEUTICALactive
CEFAZOLINE SODIQUE BIOCHEMIE
ampoule injectable / 1 g
🇸🇳SenegalBIOCHEMIEactive
KEFZOL
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
LINZEC
poudre pour préparation injectable / 1000 mg
🇸🇳SenegalORCHID HEALTH CAREactive
LINZEC
poudre pour préparation injectable / 500 mg
🇸🇳SenegalORCHID HEALTH CAREactive

CEFAZOLINE in Africa — Regulatory Overview

CEFAZOLINE is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.